Markus Hansson

28PUBLICATIONS
114CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|Jan 08, 2026
Myeloid-Derived Suppressor Cells (MDSCs) Suppress T-Cell Proliferation Less Than Mature Neutrophils in Blood and Bone Marrow From Multiple Myeloma Patients.

Julia Westerlund, Sandra Askman, Åsa Pettersson

|Jan 07, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study.

Noffar Bar, Thomas Martin, Craig C Hofmeister

|Nov 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases.

Maroulio Pertesi, Delphine Demangel, Abhishek Niroula

|Aug 05, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

Molly Went, Laura Duran-Lozano, Gisli H Halldorsson

|Mar 30, 2024
Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy.

Sandra Askman, Julia Westerlund, Åsa Pettersson

Pageof 5

Frequent Collaborators

7 joint publications

Richard S Houlston

5 joint publications

Björn Nilsson

4 joint publications

Philip Law

4 joint publications

David C Johnson